Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma is a research paper published in Neoplasia (2020). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA121275
National Institutes of Health
Grant: NCCNENZA0015
Medical University of South Carolina
Grant: P30 CA138313
NIDDK NIH HHS
Grant: P30 DK123704
National Institutes of Health
Grant: 3P30CA138313-02S2
Medical University of South Carolina - Cancer Center Support Grant
National Institutes of Health
Grant: 1R01CA121275-01A2
E2F7 & E2F8 in the control of transcription and cellular proliferation
National Institutes of Health
Grant: 5P30CA138313-09
Medical University of South Carolina - Cancer Center Support Grant
National Cancer Institute
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals